Shahrokh Shabahang, CHIEF INNOVATION OFFICER at Aditx Therapeutics, Inc. (ADTX), bought 490 shares at $2.93 ($1K) on 2021-06-01, disclosed to the SEC on 2021-06-02.
Open-market purchase of $1k ADTX by CHIEF INNOVATION OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.